OMIM Search - '+cs_neurologic:("developmental delay" OR "delayed development" OR "Delayed motor development" OR "Delayed psychomotor development" OR "Developmental motor delay" OR "Delayed walking development" OR "Delayed global development" OR "Global developmental delay" OR "Motor delay" OR "Fine motor impairment" OR "Psychomotor delay" OR "Delayed gross motor development" OR "Impaired psychomotor development" OR "Poor motor development" OR "Delay in gross motor development" OR "Lack of motor development" OR "Psychomotor retardation" OR "Lack of psychomotor development" OR "Developmental arrest" OR "Progressive psychomotor deterioration" OR "Developmental regression" OR "Psychomotor development failure" OR "Motor deterioration" OR "Motor retardation" OR "Retarded psychomotor development" OR "Delayed gross motor skills" OR "Arrest of psychomotor development" OR "Delay in motor development" OR "Delayed motor and speech development" OR "Limited gross motor development" OR "No psychomotor development" OR "Loss of motor functions" OR "Retarded motor development" OR "Motor development delayed" OR "Regression of psychomotor development" OR "Absence of development" OR "delayed early gross motor development" OR "absent psychomotor development" OR "Slowed development" OR "Poor fine motor skills" OR "Delayed motor skills" OR "Progressive motor function loss" OR "loss of motor skills" OR "Pervasive developmental disorder" OR "Motor and sensory neuropathy" OR "Delayed motor milestones" OR "Impaired fine motor skills" OR "Locomotor delay" OR "Psychomotor regression" OR "Motor deficits" OR "motor loss" OR "Loss of fine motor skills" OR "Psychomotor degeneration" OR "motor signs" OR "motor neuron" OR "motor skill delay" OR "Developmental retardation" OR "Motor impairment" OR "motor axonal neuropathy" OR "Loss of developmental skills" OR "Developmental deterioration" OR "Delayed developmental milestones" OR "Abnormal development" OR "Delayed early motor milestones" OR "Impaired motor control" OR "Motor regression" OR "Lack of neurologic development" OR "Motor abnormalities" OR "Defects in fine motor skills" OR "Impairment of gross and fine motor coordination" OR "motor incoordination" OR "Psychomotor impairment" OR "Lack of developmental progress" OR "Arrest of development" OR "Lack of development" OR "Lack of developmental progress" OR "Lack of developmental milestones" OR "Developmental disability" OR "Poor or absent global development" OR "Poor or lack of developmental progress" OR "Delayed gross motor milestones" OR "Neuromotor delay") (Search in: Prefixes: #, Chromosomes: 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, X, Y)'
Downloaded:	Nov 17, 2020
Copyright (c) 1966-2020 Johns Hopkins University OMIM, data are provided for research purposes only.

MIM Number	Title	Included Titles	Cytogenetic Location	Genomic Coordinates (From NCBI/GRCh38)	Entrez Gene ID
#617146	ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT		18p11.22-p11.21		
#618770	SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE; SPG82		17q25.3		
#614450	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6		17q21.1		
#617050	HERMANSKY-PUDLAK SYNDROME 10; HPS10		19p13.3		
#617389	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 53; DEE53		21q22.11		
#105500	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1		15q21.2		
#618242	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21		14q12		
#300232	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY; SEMDHL		Xq26.1		
#618541	HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD		16p13.3		
#605355	NEMALINE MYOPATHY 5; NEM5		19q13.42		
#618635	SIDDIQI SYNDROME; SIDDIS		20q13.12		
#618950	SULEIMAN-EL-HATTAB SYNDROME; SULEHS		20p12.1		
#615643	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6		17q21.2		
#617672	NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA		17q21.31		
#251900	MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL		19p13.2		
#618598	SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE; STAHP		21q22.11		
#618451	NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA		15q25.1		
#609152	HYPERTHYROIDISM, NONAUTOIMMUNE		14q31.1		
#604168	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN		18q23		
#275900	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20		13q13.3		
#300423	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH		Xp11.4		
#615960	PORETTI-BOLTSHAUSER SYNDROME; PTBHS		18p11.31		
#618197	MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23		22q11.21		
#618198	MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24		15q23		
#618244	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23		12q22		
#618797	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION; NEDHRIT		14q13.2		
#607131	AL-GAZALI-BAKALINOVA SYNDROME; AGBK		15q26.1		
#617182	LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI		15q21.2		
#614020	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14; MRT14		19p13.12		
#614298	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4		19q12		
#615817	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43		12q23.3		
#270450	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO, DUE TO INCREASED BINDING PROTEIN, INCLUDED	15q26.3		
#619051	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN7		19q13.12		
#616716	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5		12p13.31		
#606232	PHELAN-MCDERMID SYNDROME; PHMDS		22q13.33		
#610978	CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION; CAHTP		14q13.3		
#617404	MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY; MDCCAID		17p13.3		
#613684	RUBINSTEIN-TAYBI SYNDROME 2; RSTS2		22q13.2		
#615851	PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E		17p13.3		
#300623	FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS		Xq27.3		
#618346	MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB		21q22.3		
#617258	MYOPATHY, MYOFIBRILLAR, 8; MFM8		12p12.1		
#618050	MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57		17q23.2		
#618430	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA		22q13.2		
#618906	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISTIC FEATURES AND LANGUAGE DELAY, WITH OR WITHOUT SEIZURES; IDDALDS		17q23.2-q23.3		
#618974	LI-GHORBANI-WEISZ-HUBSHMAN SYNDROME; LIGOWS		16p11.2		
#619033	VISSERS-BODMER SYNDROME; VIBOS		16q21		
#619056	NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND DYSMORPHIC FACIES; NEDSID		16p11.2		
#618392	SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF		16q23.3-q24.1		
#300558	MENTAL RETARDATION, X-LINKED 30; MRX30		Xq23		
#602099	AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5		15q21.1		
#616439	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4		12q14.2		
#245200	KRABBE DISEASE		14q31.3		
#256731	CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5	NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED	13q22.3		
#218000	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN		15q14		
#231550	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS	ACHALASIA-ALACRIMA SYNDROME, INCLUDED	12q13.13		
#616866	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1		15q22.31		
#613179	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY		14q11.2		
#604317	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2		19q13.12		
#618213	INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE		19q13.2		
#211530	BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1		20p13		
#613454	RETT SYNDROME, CONGENITAL VARIANT		14q12		
#604360	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11		15q21.1		
#130060	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1		17q21.33		
#617284	DYSTONIA 28, CHILDHOOD-ONSET; DYT28		19q13.12		
#312080	PELIZAEUS-MERZBACHER DISEASE; PMD		Xq22.2		
#609180	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F		17p13.1		
#605021	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME		16p13.3		
#184260	ODONTOCHONDRODYSPLASIA; ODCD		14q32.12		
#601808	CHROMOSOME 18q DELETION SYNDROME		18q	18:18500000-80373285	
#244450	KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS		12q24.11		
#302060	BARTH SYNDROME; BTHS		Xq28		
#613849	OSTEOGENESIS IMPERFECTA, TYPE XII; OI12		12q13.13		
#256850	GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1		16q23.2		
#300842	MCLEOD SYNDROME; MCLDS	MCLEOD SYNDROME WITH CHRONIC GRANULOMATOUS DISEASE, INCLUDED	Xp21.1		
#617721	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9		14q32.2		
#616212	LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6		16q21		
#601338	CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS		19q13.2		
#300352	CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1		Xq28		
#618060	INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA		15q22.2		
#618150	SAUL-WILSON SYNDROME; SWILS		16q22.1		
#618776	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34; MC1DN34		17q25.3		
#612301	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7		18q21.33		
#601780	CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6		15q23		
#604004	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1		22q13.33		
#221770	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 1; PLOSL1		19q13.12		
#135700	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B, INCLUDED; CFEOM3B, INCLUDED	12q12		
#215470	BOUCHER-NEUHAUSER SYNDROME; BNHS		19p13.2		
#607485	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	APHASIA, PRIMARY PROGRESSIVE, INCLUDED; PPA, INCLUDED	17q21.31		
#608627	AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8		20q13.32		
#614153	SPINOCEREBELLAR ATAXIA 36; SCA36		20p13		
#615048	SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ		22q11.23		
#615512	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY; TPID		12p13.31		
#615911	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2		22q11.23		
#616840	PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK23		15q22.2		
#225790	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH		14q24.3		
#260565	PEHO SYNDROME; PEHO		17q12		
#300475	DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	CONTIGUOUS ABCD1/DXS1375E DELETION SYNDROME, INCLUDED; CADDS, INCLUDED	Xq28		
#614019	LISSENCEPHALY 4; LIS4		16p13.11		
#615182	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD		22q11.21		
#615473	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17; DEE17		16q13		
#616570	CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3		13q33.1		
#616647	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35; DEE35		20p13		
#616681	MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE; MCPH16		12q24.33		
#236600	HYDROCEPHALUS, CONGENITAL, 1; HYC1		14q32.11-q32.12		
#617900	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8		12q14.2		
#618236	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14		19p13.3		
#618416	METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN		19p13.11		
#618886	PSEUDO-TORCH SYNDROME 3; PTORCH3		12q13.3		
#619063	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19		20p11.23		
#301013	MENTAL RETARDATION, X-LINKED 107; MRX107		Xq24		
#254800	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG		21q22.3		
#618564	MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT; PADMAL		13q34		
#618912	SORBITOL DEHYDROGENASE DEFICIENCY WITH PERIPHERAL NEUROPATHY; SORDD		15q21.1		
#117000	CENTRAL CORE DISEASE OF MUSCLE; CCD	MINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED	19q13.2		
#118700	CHOREA, BENIGN HEREDITARY; BHC		14q13.3		
#605259	SPINOCEREBELLAR ATAXIA 13; SCA13		19q13.33		
#300166	MICROPHTHALMIA, SYNDROMIC 2; MCOPS2		Xp11.4		
#130720	LATERAL MENINGOCELE SYNDROME; LMNS		19p13.12		
#145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS		1q23.3, 10q21.3, 17p12, 19q13.2		
#180800	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA		1q23.3, 17p12		
#181405	SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA		12q24.11		
#182600	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A		14q22.1		
#219200	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A		12q24.31		
#602541	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC		22q13.33		
#248900	MAST SYNDROME		15q22.31		
#251450	DESBUQUOIS DYSPLASIA 1; DBQD1	DESBUQUOIS DYSPLASIA, KIM VARIANT, INCLUDED	17q25.3		
#255320	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA		19q13.2		
#255995	MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB		12q13.3		
#264700	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A		12q14.1		
#277440	VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A		12q13.11		
#300067	LISSENCEPHALY, X-LINKED, 1; LISX1	SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED; SCLH, INCLUDED	Xq23		
#300615	BRUNNER SYNDROME; BRNRS	ANTISOCIAL BEHAVIOR, SUSCEPTIBILITY TO, INCLUDED	Xp11.3		
#302500	SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1		Xq28		
#302800	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1		Xq13.1		
#309350	MELNICK-NEEDLES SYNDROME; MNS		Xq28		
#309800	MICROPHTHALMIA, SYNDROMIC 1; MCOPS1		Xq28		
#310440	MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX		Xq28		
#311070	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5		Xq22.3		
#608747	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY		12q23.2		
#608931	MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C		17p13.2		
#611603	LISSENCEPHALY 3; LIS3		12q13.12		
#612438	LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6		19p13.3		
#613027	GLYCOGEN STORAGE DISEASE IXc; GSD9C		16p11.2		
#613153	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5		19q13.32		
#613156	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2; MDDGB2		14q24.3		
#613158	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2		14q24.3		
#613204	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY		12q13.2		
#613391	DEAFNESS, AUTOSOMAL RECESSIVE 84A; DFNB84A		12q21.31		
#613402	MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ		19q13.33		
#609311	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H		12p11.21		
#610687	NEMALINE MYOPATHY 7; NEM7		14q13.1		
#610773	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY; MPCD		12q23.1		
#610954	PITT-HOPKINS SYNDROME; PTHS		18q21.2		
#613717	TREACHER COLLINS SYNDROME 2; TCS2		13q12.2		
#613803	MEIER-GORLIN SYNDROME 3; MGORS3		16q11.2		
#614198	MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16		17q23.3		
#614228	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O		14q32.31		
#614869	USHER SYNDROME, TYPE IJ; USH1J		15q25.1		
#614895	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F		19q13.2		
#615582	LOEYS-DIETZ SYNDROME 5; LDS5		14q24.3		
#616078	MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29		18q12.3		
#616313	MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A		17p13.1		
#616324	MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B		17p13.2		
#616723	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA		16q13		
#616733	COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8		16p12.3		
#617066	MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC		15q22.31		
#618124	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID		21q22.3		
#618323	MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25		12p13.31		
#618775	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10; MC3DN10		19q12		
#618793	INTELLECTUAL DEVELOPMENTAL DISORDER 62; MRD62		17p13.1		
#619028	COENZYME Q10 DEFICIENCY, PRIMARY, 9; COQ10D9		12q24.31		
#271930	STRIATONIGRAL DEGENERATION, INFANTILE; SNDI		19q13.33		
#300322	LESCH-NYHAN SYNDROME; LNS	HPRT DEFICIENCY, NEUROLOGIC VARIANT, INCLUDED	Xq26.2-q26.3		
#300803	MENTAL RETARDATION, X-LINKED 97; MRX97		Xq21.1		
#300844	MENTAL RETARDATION, X-LINKED 19; MRX19		Xp22.12		
#300888	HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT; CHTE		Xq26.1		
#300990	MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN		Xq23		
#613982	OSTEOGENESIS IMPERFECTA, TYPE VI; OI6		17p13.3		
#616113	POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS		15q21.2		
#616734	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2		18q12.1-q12.2		
#617102	SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16		20q13.12		
#617439	CRANIOSYNOSTOSIS 7; CRS7		15q22.31		
#617808	COFFIN-SIRIS SYNDROME 6; CSS6		12q12		
#618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF		19q13.42		
#618840	ALOPECIA-MENTAL RETARDATION SYNDROME 4; APMR4		21q22.3		
#618889	LIBERFARB SYNDROME; LIBF		22q12.2		
#602535	MARSHALL-SMITH SYNDROME; MRSHSS		19p13.13		
#247200	MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	CHROMOSOME 17p13.3 DELETION SYNDROME, INCLUDED	17p13.3		
#613752	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY		20q11.22		
#614753	SOTOS SYNDROME 2; SOTOS2		19p13.13		
#145420	HYPERTELORISM, TEEBI TYPE; TBHS		22q11.23		
#618229	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7		18p11.22		
#308350	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1; DEE1		Xp21.3		
#242150	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KIDAR		22q12.2		
#613320	SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM		16p13.3		
#300661	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	GOUT, PRPS-RELATED, INCLUDED	Xq22.3		
#618419	GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM		14q13.2		
#226750	KOHLSCHUTTER-TONZ SYNDROME; KTZS		16p13.3		
#300672	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2; DEE2		Xp22.13		
#614558	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13; DEE13		12q13.13		
#614924	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12		16p12.2		
#615369	EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC		15q26.1		
#615398	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3		20q13.12		
#300884	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36; DEE36	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Is, INCLUDED; CDG1S, INCLUDED	Xq23		
#300986	MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB		Xq22.1		
#617193	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT		17q25.3		
#617600	MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45		19q13.2		
#617664	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32		16p13.3		
#300148	MEHMO SYNDROME; MEHMO		Xp22.11		
#609029	EMANUEL SYNDROME		22q11.2	22:17400000-25500000	
#176270	PRADER-WILLI SYNDROME; PWS	PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED	15q11.2, 15q11.2		
#208085	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1		15q26.1		
#211380	ELSAHY-WATERS SYNDROME; ESWS		16q21		
#218340	TEMTAMY SYNDROME; TEMTYS		12p13.31		
#604377	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 2; MC4DN2		22q13.33		
#300261	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, ARMFIELD TYPE; MRXSA		Xq28	X:148000000-156040895	
#300849	MENTAL RETARDATION, X-LINKED 41; MRX41		Xq28		
#300886	MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32		Xq28		
#300928	MENTAL RETARDATION, X-LINKED 101; MRX101		Xq22.3		
#300953	TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE; TTD5		Xq24		
#301020	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12		Xq24		
#301022	MULLEGAMA-KLEIN-MARTINEZ SYNDROME; MKMS		Xq25		
#301024	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108		Xp11.3		
#301025	PAGANINI-MIOZZO SYNDROME; MRXSPM		Xq26.2		
#301029	SHUKLA-VERNON SYNDROME; SHUVER		Xq26.1		
#301032	BASILICATA-AKHTAR SYNDROME; MRXSBA		Xp22.2		
#301039	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE; MRXSHD		Xq24		
#301041	WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED; WRWFFR		Xq11.2		
#301043	HOLOPROSENCEPHALY 13, X-LINKED; HPE13		Xq25		
#305450	OPITZ-KAVEGGIA SYNDROME; OKS		Xq13.1		
#309590	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST		Xp11.22		
#606220	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS		13q22.3		
#606744	SECKEL SYNDROME 2; SCKL2		18q11.2		
#608779	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E		16p12.2		
#608799	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E		20q13.13		
#613404	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2		14q24.3		
#610090	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD		17q21.32		
#610505	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3		12q14.1		
#611209	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G		17q25.1		
#614306	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT		12q13.13		
#614654	COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5		16q21		
#614947	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15		15q22.31		
#615926	WEBB-DATTANI SYNDROME; WEDAS		15q25.1		
#616763	LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD		19q13.2		
#616784	JOUBERT SYNDROME 26; JBTS26		16p12.1		
#616811	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29		22q12.3		
#616878	METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN		22q11.21		
#616954	YOU-HOOVER-FONG SYNDROME; YHFS		16p13.3		
#617011	MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR		15q22.31		
#617062	OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS		20p13		
#617162	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 46; DEE46		19q13.33		
#617228	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31; COXPD31		13q12.12		
#617303	MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS		12q24.31		
#617364	CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA; CHDED		14q12		
#617393	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION; NECFM		19p13.13		
#617475	SPECIFIC GRANULE DEFICIENCY 2; SGD2		17q23.3		
#617854	MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56		17q23.1		
#617862	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA		14q21.1		
#617913	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR		17p13.3		
#618009	INTELLECTUAL DEVELOPMENTAL DISORDER 61; MRD61		17q23.2		
#618141	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67		12q24.11-q24.12		
#618143	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18		17q11.2		
#618147	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	CHROMOSOME 14q32 DELETION SYNDROME, INCLUDED	14q32.2		
#618205	SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS		17p13.1		
#618218	BAKER-GORDON SYNDROME; BAGOS		12q21.2		
#618238	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16		20p12.1		
#618249	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28		19p13.11		
#618253	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33		22q13.2		
#618268	TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS		17q23.3		
#618272	GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW		14q32.13		
#618273	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM		19p13.13		
#618302	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68		19p13.13		
#618316	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF		17q25.1		
#618324	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2		16q22.1		
#618329	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37		19p13.3		
#618360	BRAIN SMALL VESSEL DISEASE 3; BSVD3		19p13.11		
#618367	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM		15q25.1		
#618374	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72		17q12		
#618443	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA		16p13.3		
#618480	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI		19p13.13		
#618494	CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA		12p13.31		
#618500	HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12		16q21		
#618505	NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA		17p13.1		
#618548	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4; MCAHS4		16p13.3		
#618559	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 79; EIEE79		15q12		
#618577	NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES; NEDBAF		17q25.3		
#618580	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80; DEE80		15q21.3		
#618590	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS; NEDBSS		20q11.22		
#618603	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES; NEDHIB		17p13.1		
#618608	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES; IDNADFS	CHROMOSOME 12q15 DELETION SYNDROME, INCLUDED	12q15		
#618644	OSTEOGENESIS IMPERFECTA, TYPE XX; OI20		15q25.1		
#618677	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 10; CDCBM10		19p13.3		
#618721	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82; DEE82		16q21		
#618760	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS; NEDHAHM		17p13.1		
#618774	CEBALID SYNDROME; CEBALID		22q12.1		
#618779	COFFIN-SIRIS SYNDROME 11; CSS11		12q13.12		
#618828	NABAIS SA-DE VRIES SYNDROME, TYPE 1; NSDVS1		17q21.33		
#618829	NABAIS SA-DE VRIES SYNDROME, TYPE 2; NSDVS2		17q21.33		
#618859	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISTIC FEATURES AND/OR STRUCTURAL BRAIN ABNORMALITIES; NEDASB		19q13.32		
#618862	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES; NEDHYMS		21q22.3		
#618929	AGENESIS OF CORPUS CALLOSUM, CARDIAC, OCULAR, AND GENITAL SYNDROME; ACOGS		18q12.1		
#618951	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 45; COXPD45		17q25.3		
#619000	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEIZURES AND LANGUAGE DELAY; IDDSELD		12q24.31		
#619055	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN12		19p13.2		
#619058	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 14; MC4DN14		17q21.2		
#619064	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20; MC4DN20		15q24.2		
#617899	LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14		13q13.3		
#618186	NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3		17q21.2		
#618663	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 81; DEE81		15q21.2		
#616286	LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7		17q21.2		
#203700	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A		15q26.1		
#256600	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A		22q13.1		
#602473	ENCEPHALOPATHY, ETHYLMALONIC; EE		19q13.31		
#300816	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6		Xq26.1		
#613559	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7		12q24.31		
#615338	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 16; DEE16		16p13.3		
#617235	MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY		12q13.3		
#300088	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 9; DEE9		Xq22.1		
#617140	ZTTK SYNDROME; ZTTKS		21q22.11		
#615873	HELSMOORTEL-VAN DER AA SYNDROME; HVDAS		20q13.13		
#301040	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX		Xq21.1		
#606854	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL; BFPP		16q21		
#607196	MICROCEPHALY, AMISH TYPE; MCPHA		17q25.1		
#252500	MUCOLIPIDOSIS II ALPHA/BETA		12q23.2		
#610377	MEVALONIC ACIDURIA; MEVA		12q24.11		
#278780	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	XERODERMA PIGMENTOSUM, TYPE G/COCKAYNE SYNDROME, INCLUDED; XPG/CS, INCLUDED	13q33.1		
#233910	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE, INCLUDED	14q22.2		
#300607	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8; DEE8		Xq11.1		
#204200	CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3		16p12.1		
#272800	TAY-SACHS DISEASE; TSD	TAY-SACHS DISEASE, JUVENILE, INCLUDED	15q23		
#270550	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS		13q12.12		
#617159	SIFRIM-HITZ-WEISS SYNDROME; SIHIWES		12p13.31		
#203450	ALEXANDER DISEASE; ALXDRD		17q21.31		
#236792	L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA		14q21.3		
#252011	MITOCHONDRIAL COMPLEX II DEFICIENCY		5p15.33, 11q23.1, 19q13.12		
#603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	VANISHING WHITE MATTER LEUKODYSTROPHY WITH OVARIAN FAILURE, INCLUDED	1p34.1, 2p23.3, 3q27.1, 12q24.31, 14q24.3		
#300243	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH		Xq26.3		
#300872	AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6		Xq28		
#610678	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4		16p11.2		
#616645	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 34; DEE34		20q13.12		
#617054	STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET; SNDC		16q22.1-q22.2		
#618224	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3		19p13.3		
#618321	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2		13q34		
#618331	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB		16q24.3		
#618876	EPILEPSY, PROGRESSIVE MYOCLONIC, 11; EPM11		19p13.3		
#619060	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16		16q24.1		
#619061	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 17; MC4DN17		14q32.33		
#616260	TENORIO SYNDROME; TNORS		18q12.1		
#618731	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES; NEDBAVC		12q24.31		
#300114	RAYNAUD-CLAES SYNDROME; MRXSRC		Xp22.2		
#188400	DIGEORGE SYNDROME; DGS	DIGEORGE SYNDROME CHROMOSOME REGION, INCLUDED; DGCR, INCLUDED	22q11.21		
#216360	COACH SYNDROME		4p15.32, 8q22.1, 16q12.2		
#600348	BAND HETEROTOPIA; BH		14q32.2		
#225753	PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4		17q25.1		
#239500	HYPERPROLINEMIA, TYPE I; HYRPRO1		22q11.21		
#248500	MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA		19p13.13		
#251270	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1		22q13.33		
#251300	GALLOWAY-MOWAT SYNDROME 1; GAMOS1		15q25.2		
#252650	MUCOLIPIDOSIS IV; ML4		19p13.2		
#264470	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY		17q25.1		
#300434	STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX		Xp11.22		
#300438	HSD10 MITOCHONDRIAL DISEASE; HSD10MD		Xp11.22		
#300523	ALLAN-HERNDON-DUDLEY SYNDROME; AHDS		Xq13.2		
#300590	CORNELIA DE LANGE SYNDROME 2; CDLS2		Xp11.22		
#300749	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH		Xp11.4		
#300804	JOUBERT SYNDROME 10; JBTS10		Xp22.2		
#300831	CK SYNDROME		Xq28		
#300850	MENTAL RETARDATION, X-LINKED 90; MRX90		Xq13.1		
#300855	OGDEN SYNDROME; OGDNS		Xq28		
#300868	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2		Xp22.2		
#300869	CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME		Xq27.3-q28	X:143000000-156040895	
#300894	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5		Xp11.23		
#300896	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M		Xp11.23		
#300912	MENTAL RETARDATION, X-LINKED 98; MRX98		Xq13.3		
#300919	MENTAL RETARDATION, X-LINKED 99; MRX99		Xp11.4		
#300934	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y		Xq28		
#300960	MEND SYNDROME; MEND		Xp11.23		
#300963	RITSCHER-SCHINZEL SYNDROME 2; RTSC2		Xp11.23		
#300966	MENTAL RETARDATION, X-LINKED, SYNDROMIC 33; MRXS33		Xq13.1		
#300967	MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34		Xq13.1		
#300968	MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED; MRXS99F		Xp11.4		
#300978	TONNE-KALSCHEUER SYNDROME; TOKAS		Xq13.2		
#300982	MENTAL RETARDATION, X-LINKED 103; MRX103		Xp22.11		
#300997	MENTAL RETARDATION, X-LINKED 106; MRX106		Xq13.1		
#300998	MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35		Xq28		
#301006	GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2		Xq28		
#301008	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG		Xp22.12		
#301835	ARTS SYNDROME; ARTS		Xq22.3		
#304340	PETTIGREW SYNDROME; PGS		Xp22.2		
#308205	IFAP SYNDROME 1, WITH OR WITHOUT BRESHECK SYNDROME; IFAP1		Xp22.12		
#309530	MENTAL RETARDATION, X-LINKED 1; MRX1		Xp11.22		
#309541	METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE		Xq28		
#309585	WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS		Xq12		
#311510	WAISMAN SYNDROME; WSMN		Xq28		
#314580	WIEACKER-WOLFF SYNDROME; WRWF		Xq11.2		
#606164	DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15		19p13.2		
#608097	PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM		20q13.13		
#608363	CHROMOSOME 22q11.2 DUPLICATION SYNDROME		22q11.2	22:17400000-25500000	
#608443	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3		19p13.12		
#611560	JOUBERT SYNDROME 7; JBTS7		16q12.2		
#611584	WAARDENBURG SYNDROME, TYPE 2E; WS2E		22q13.1		
#612626	CHROMOSOME 15q26-qter DELETION SYNDROME		15q26-qter	15:88500000-101991189	
#612714	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS		20q11.21		
#612718	CEREBRAL CREATINE DEFICIENCY SYNDROME 3; CCDS3		15q21.1		
#613026	CHROMOSOME 19q13.11 DELETION SYNDROME, DISTAL		19q13.11	19:31900000-35100000	
#613161	BETA-UREIDOPROPIONASE DEFICIENCY; UPB1D		22q11.23		
#613457	CHROMOSOME 14q11-q22 DELETION SYNDROME		14q11-q22	14:17200000-57600000	
#613489	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J		16q22.1		
#609528	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME		22q11.21		
#610185	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2		17p13.3		
#610536	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA		17q21.31		
#611087	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE		17q23.3		
#613604	CHROMOSOME 16p12.2-p11.2 DELETION SYNDROME, 7.1- TO 8.7-MB		16p12.2-p11.2	16:21200000-35300000	
#613720	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7; DEE7		20q13.33		
#613722	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12; DEE12		20p12.3		
#613744	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51		15q21.2		
#613970	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6		12p13.1		
#614039	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1		16q24.3		
#614067	SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52		14q12		
#614080	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1		18q21.33		
#614105	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD		14q24.3		
#614294	CHROMOSOME 15q25 DELETION SYNDROME		15q25	15:78000000-88500000	
#614322	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12		16q23.1-q23.2		
#614340	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27; MRT27		15q26.3		
#614388	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1; EMPF1		12p11.21		
#614483	BRAIN SMALL VESSEL DISEASE 2; BSVD2		13q34		
#614541	CHROMOSOME 16q22 DELETION SYNDROME		16q22	16:66600000-74100000	
#614559	INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD		22q13.2		
#614576	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L		13q14.11		
#614608	COFFIN-SIRIS SYNDROME 3; CSS3		22q11.23		
#614609	COFFIN-SIRIS SYNDROME 4; CSS4		19p13.2		
#614820	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2		19q13.2		
#614857	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ		14q24.3		
#614961	PONTOCEREBELLAR HYPOPLASIA, TYPE 8; PCH8		16q24.3		
#614970	JOUBERT SYNDROME 20; JBTS20		16q23.1		
#615031	SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE; SPG49		14q32.31		
#615035	SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55		12q24.31		
#615401	IMMUNODEFICIENCY 8; IMD8		16p11.2		
#615412	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4		17q21.2		
#615440	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17; COXPD17		17p12		
#615485	BAINBRIDGE-ROPERS SYNDROME; BRPS		18q12.1		
#615501	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC		14q23.3		
#615516	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38		15q13.1		
#615547	SCHAAF-YANG SYNDROME; SHFYNG		15q11.2		
#615637	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41		19q13.32		
#615656	CHROMOSOME 15q11.2 DELETION SYNDROME		15q11.2	15:20500000-25500000	
#615716	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4; HPMRS4		17q12		
#615751	CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD		16q24.2		
#615833	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 21; DEE21		12p13.31		
#615905	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25, WITH AMELOGENESIS IMPERFECTA; DEE25		17p13.1		
#615942	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44; MRT44		17q25.1		
#616025	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11		17q12		
#616056	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26; DEE26		20q13.13		
#616081	PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C		13q13.3		
#616139	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27; DEE27		12p13.1		
#616172	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9		16p11.2		
#616198	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23; COXPD23		19p13.11		
#616211	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28; DEE28		16q23.1-q23.2		
#616263	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD		17q23.1		
#616266	CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD		13q32.3-q33.1		
#616330	MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18		20p12.2		
#616339	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29; DEE29		16q22.1		
#616341	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 30; DEE30		21q22.3		
#616362	MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36		19q13.41		
#616393	MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38		20q13.33		
#616409	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 33; DEE33		20q13.33		
#616449	BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS		19q13.33		
#616539	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26		14q23.1		
#616540	EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9		19p13.3		
#616579	MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40		13q34		
#616606	RING CHROMOSOME 14 SYNDROME		Chr.14		
#616652	YUAN-HAREL-LUPSKI SYNDROME; YUHAL		17p12-p11.2	17:10800000-22700000	
#616654	JOUBERT SYNDROME 24; JBTS24		12q24.31		
#616672	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27		13q34		
#616680	SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE; SPG75		19q13.12		
#616789	MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD		12q24.21		
#616803	LAMB-SHAFFER SYNDROME; LAMSHF		12p12.1		
#616829	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp; CDG2P		17q11.2		
#616863	HAO-FOUNTAIN SYNDROME; HAFOUS	CHROMOSOME 16p13.2 DELETION SYNDROME, INCLUDED	16p13.2		
#616898	CHROMOSOME 15q14 DELETION SYNDROME		15q14	15:33400000-39800000	
#616901	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR; DEDSSH		17p13.3		
#616920	HEART AND BRAIN MALFORMATION SYNDROME; HBMS		19q13.31		
#616938	COFFIN-SIRIS SYNDROME 5; CSS5		17q21.2		
#617090	MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17		12q24.23		
#617113	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 43; DEE43		15q12		
#617157	SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES; SBIDDS		16q22.1		
#617173	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA; IDDCA		15q21.2		
#617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57		19q13.42		
#617201	PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7		18q21.31		
#617237	IMMUNODEFICIENCY 49; IMD49		14q32.2		
#617255	LISSENCEPHALY 8; LIS8		12q21.32		
#617270	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58		18q12.2		
#617276	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 48; DEE48		15q25.2		
#617350	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52; DEE52		19q13.11		
#617450	JANSEN-DE VRIES SYNDROME; JDVS		17q23.2		
#617493	NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM		16q13		
#617519	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND		19q13.2		
#617542	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2		18q21.2		
#617557	GABRIELE-DE VRIES SYNDROME; GADEVS		14q32.2		
#617562	MECKEL SYNDROME 13; MKS13	JOUBERT SYNDROME 29, INCLUDED; JBTS29, INCLUDED	17p13.1		
#617563	OROFACIODIGITAL SYNDROME XVI; OFD16		17p13.1		
#617599	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 55; DEE55		21q22.13		
#617694	AL KAISSI SYNDROME; ALKAS		16q24.3		
#617698	3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9		19q13.2		
#617729	GALLOWAY-MOWAT SYNDROME 3; GAMOS3		14q11.2		
#617730	GALLOWAY-MOWAT SYNDROME 4; GAMOS4		20q13.12		
#617755	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL		17q24.2		
#617807	NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW		19p13.2		
#617977	NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS		17q25.3		
#618005	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1		14q23.3		
#618067	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66		14q32.33		
#618087	SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND		17q21.33		
#618088	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS		14q24.3		
#618092	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA		14q32.2		
#618103	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64		15q24.3		
#618165	BONE MARROW FAILURE SYNDROME 5; BMFS5		17p13.1		
#103050	ADENYLOSUCCINASE DEFICIENCY; ADSLD		22q13.1		
#114300	ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3		18p11.22-p11.21		
#234200	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1		20p13		
#300486	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE		Xq12		
#309549	MENTAL RETARDATION, X-LINKED 9; MRX9		Xp11.23		
#612073	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5		13q14.2		
#613076	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT AND DEVELOPMENTAL DELAY; MPMCD		16p13.3		
#613385	AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD		20q11.22		
#609640	FRIAS SYNDROME		14q22.1-q22.3	14:50400000-57600000	
#614852	MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9		15q21.1		
#617941	SHWACHMAN-DIAMOND SYNDROME 2; SDS2		15q25.2		
#105830	ANGELMAN SYNDROME; AS	ANGELMAN SYNDROME CHROMOSOME REGION, INCLUDED; ANCR, INCLUDED	15q11.2		
#605275	NOONAN SYNDROME 2; NS2		22q11.21		
#609053	FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI		15q26.1		
#609136	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH		22q13.1		
#137940	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS		20q13.33		
#145410	OPITZ GBBB SYNDROME, TYPE II; GBBB2		22q11.23		
#146390	CHROMOSOME 18p DELETION SYNDROME		18p		
#147920	KABUKI SYNDROME 1; KABUK1		12q13.12		
#148050	KBG SYNDROME; KBGS		16q24.3		
#170100	PROLIDASE DEFICIENCY		19q13.11		
#201470	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD		12q24.31		
#210720	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2		21q22.3		
#214450	GRISCELLI SYNDROME, TYPE 1; GS1		15q21.2		
#600268	OCULOECTODERMAL SYNDROME; OES		12p12.1		
#600373	CODAS SYNDROME		19p13.3		
#601005	TIMOTHY SYNDROME; TS		12p13.33		
#601321	NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS		17q11.2		
#601678	BARTTER SYNDROME, TYPE 1, ANTENATAL; BARTS1		15q21.1		
#601776	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1		15q15.1		
#603387	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1; MPPH1		19p13.11		
#605039	BOHRING-OPITZ SYNDROME; BOPS		20q11.21		
#243500	ISOVALERIC ACIDEMIA; IVA		15q15.1		
#248360	MALONYL-CoA DECARBOXYLASE DEFICIENCY		16q23.3		
#250800	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	METHEMOGLOBINEMIA, TYPE I, INCLUDED	22q13.2		
#251110	METHYLMALONIC ACIDURIA, cblB TYPE		12q24.11		
#253270	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY		21q22.13		
#257220	NIEMANN-PICK DISEASE, TYPE C1; NPC1	NIEMANN-PICK DISEASE, TYPE D, INCLUDED	18q11.2		
#257300	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1		15q15.1		
#261540	PETERS-PLUS SYNDROME; PTRPLS		13q12.3		
#262190	PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES		19p13.2		
#266510	PEROXISOME BIOGENESIS DISORDER 3B; PBD3B		17q12		
#268305	ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES		17q25.3		
#272300	SULFITE OXIDASE DEFICIENCY, ISOLATED; ISOD		12q13.2		
#277470	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A		17q25.1		
#300000	OPITZ GBBB SYNDROME, TYPE I; GBBB1		Xp22.2		
#300004	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA		Xp21.3		
#300555	DENT DISEASE 2		Xq26.1		
#300653	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY		Xq21.1		
#300673	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS		Xq28		
#300799	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR		Xq26.1		
#300845	MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, AND FACIAL DYSMORPHISM; MYMY4		Xq28	X:148000000-156040895	
#300867	KABUKI SYNDROME 2; KABUK2		Xp11.3		
#300895	OHDO SYNDROME, X-LINKED; OHDOX		Xq13.1		
#300958	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE; MRXSSB		Xp11.4		
#300983	MENTAL RETARDATION, X-LINKED 104; MRX104		Xp22.2		
#301030	VAN ESCH-O'DRISCOLL SYNDROME; VEODS		Xp22.1-p21.3		
#301031	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc; CDG1CC		Xq21.1		
#302950	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1		Xp22.33		
#303110	CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION		Xq21	X:76800000-99100000	
#304110	CRANIOFRONTONASAL SYNDROME; CFNS		Xq13.1		
#306000	GLYCOGEN STORAGE DISEASE IXa1; GSD9A1	GLYCOGEN STORAGE DISEASE IXa2, INCLUDED; GSD9A2, INCLUDED	Xp22.13		
#311250	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO		Xp11.4		
#311900	TARP SYNDROME; TARPS		Xp11.3		
#600001	HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA		18q11.2		
#606593	LIG4 SYNDROME		13q33.3		
#607432	LISSENCEPHALY 1; LIS1	SUBCORTICAL LAMINAR HETEROTOPIA, INCLUDED; SCLH, INCLUDED	17p13.3		
#607625	NIEMANN-PICK DISEASE, TYPE C2; NPC2		14q24.3		
#608840	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6; MDDGB6		22q12.3		
#611867	CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL		22q11.2	22:17400000-25500000	
#612736	CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2		19p13.3		
#612938	GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM; GDFD		16q12.2		
#612940	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B		17q25.3		
#613180	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 8; CDCBM8		22q11.21		
#613355	CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME		17q23.1-q23.2	17:59500000-63100000	
#613458	CHROMOSOME 16p13.3 DUPLICATION SYNDROME		16p13.3		
#609942	NOONAN SYNDROME 3; NS3		12p12.1		
#610125	MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	RETINAL DYSTROPHY, EARLY-ONSET, WITH OR WITHOUT PITUITARY DYSFUNCTION, INCLUDED	14q22.3		
#610131	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4		17q23.3		
#610443	KOOLEN-DE VRIES SYNDROME; KDVS		17q21.31		
#610756	CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2		19q13.32		
#610758	CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4		19q13.32		
#610883	POTOCKI-LUPSKI SYNDROME; PTLS		17p11.2	17:16100000-22700000	
#613662	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B		15q26.1		
#613680	BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS		16p13.3		
#613776	CHROMOSOME 17p13.1 DELETION SYNDROME		17p13.1	17:6500000-10800000	
#614104	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7; MRD7		21q22.13		
#614129	PERRAULT SYNDROME 3; PRLTS3		19p13.3		
#614231	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS		18q21.1		
#614561	LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS; LCC		17p13.1		
#614851	SECKEL SYNDROME 7; SCKL7		14q22.1		
#614976	CARPENTER SYNDROME 2; CRPT2		19q13.2		
#615157	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2		17p12		
#615190	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 4, INCLUDED; DKCA4, INCLUDED	20q13.33		
#615220	OSTEOGENESIS IMPERFECTA, TYPE XV; OI15		12q13.12		
#615279	CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3		15q22.31		
#615280	CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4		19p13.3		
#615314	CRANIOSYNOSTOSIS 3; CRS3		15q21.3		
#615502	MENTAL RETARDATION, AUTOSOMAL DOMINANT 21; MRD21		16q22.1		
#615538	CHROMOSOME 22q13 DUPLICATION SYNDROME		22q13	22:37200000-50818468	
#615560	OTOFACIOCERVICAL SYNDROME 2; OTFCS2		20p11.22		
#615777	DESBUQUOIS DYSPLASIA 2; DBQD2		16p12.3		
#615779	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4		15q26.2		
#615981	BARDET-BIEDL SYNDROME 2; BBS2		16q13		
#615991	BARDET-BIEDL SYNDROME 14; BBS14		8q22.1, 12q21.32		
#616145	CATEL-MANZKE SYNDROME; CATMANS		13q32.1		
#616222	TEMPLE SYNDROME		14q32	14:89300000-107043718	
#616559	NOONAN SYNDROME 9; NS9		14q21.3		
#616843	LYMPHATIC MALFORMATION 6; LMPHM6		16q24.3		
#617063	MEIER-GORLIN SYNDROME 7; MGORS7		22q11.21		
#617106	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42; DEE42		19p13.13		
#617767	JOUBERT SYNDROME 33; JBTS33		13q21.3-q22.1		
#617781	RETINITIS PIGMENTOSA 80; RP80		16p13.3		
#617883	FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS		17q21.31		
#618223	VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD		17q23.2		
#618234	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11		15q15.1		
#618248	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27		15q22.31		
#618332	MENKE-HENNEKAM SYNDROME 1; MKHK1		16p13.3		
#618333	MENKE-HENNEKAM SYNDROME 2; MKHK2		22q13.2		
#618348	GALLOWAY-MOWAT SYNDROME 7; GAMOS7		12q15		
#618371	TURNPENNY-FRY SYNDROME; TPFS		17q12		
#618529	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2		17p13.3		
#618702	SHORT STATURE AND MICROCEPHALY WITH GENITAL ANOMALIES; SSMGA		16q22.1		
#618752	NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT; SCN8		14q13.2		
#618786	IMAGAWA-MATSUMOTO SYNDROME; IMMAS		17q11.2		
#618820	GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME; GUBS		12q21.2-q21.3		
#619013	RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2; RILDBC2		19p13.13		
#121200	SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1	EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	20q13.33		
#223800	DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC		18q21.1		
#607143	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G		22q13.33		
#212065	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A		16p13.2		
#600987	CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR		15q14		
#601238	CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY		19p13.3		
#604273	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1		17p11.2		
#605013	MICROHYDRANENCEPHALY; MHAC		16p13.11		
#238970	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME; HHHS		13q14.11		
#242840	VICI SYNDROME; VICIS		18q12.3-q21.1		
#268130	REVESZ SYNDROME		14q12		
#300215	LISSENCEPHALY, X-LINKED, 2; LISX2	HYDRANENCEPHALY AND ABNORMAL GENITALIA, INCLUDED	Xp21.3		
#300260	LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL		Xq28		
#300887	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2		Xq21.1		
#307030	GLYCEROL KINASE DEFICIENCY; GKD		Xp21.2		
#312170	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	LACTIC ACIDEMIA, THIAMINE-RESPONSIVE, INCLUDED	Xp22.12		
#606054	PROPIONIC ACIDEMIA		3q22.3, 13q32.3		
#607596	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A		14q32.2		
#607932	MICROPHTHALMIA, SYNDROMIC 6; MCOPS6		14q22.2		
#608540	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K		16p13.3		
#613163	GABA-TRANSAMINASE DEFICIENCY		16p13.2		
#613398	WARSAW BREAKAGE SYNDROME; WABS		12p11.21		
#610333	AICARDI-GOUTIERES SYNDROME 4; AGS4		19p13.13		
#611174	HAMAMY SYNDROME; HMMS		16q12.2		
#613661	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P		13q14.3		
#613805	MEIER-GORLIN SYNDROME 5; MGORS5		17q21.2		
#614219	ADAMS-OLIVER SYNDROME 2; AOS2		19p13.2		
#615095	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10		20q13.12		
#615419	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1		13q32.3-q33.1		
#616108	RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS		14q24.1		
#617241	LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS		15q13.1		
#608149	KAGAMI-OGATA SYNDROME		14q32	14:89300000-107043718	
#600638	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A		16q24.3		
#229050	FOLATE MALABSORPTION, HEREDITARY		17q11.2		
#300055	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13; MRXS13		Xq28		
#300257	DANON DISEASE		Xq24		
#300979	Xq25 DUPLICATION SYNDROME	Xq25 TRIPLICATION SYNDROME, INCLUDED	Xq25	X:121800000-129500000	
#305000	DYSKERATOSIS CONGENITA, X-LINKED; DKCX	HOYERAAL-HREIDARSSON SYNDROME, INCLUDED; HHS, INCLUDED	Xq28		
#612541	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	DURSUN SYNDROME, INCLUDED	17q21.31		
#612952	AICARDI-GOUTIERES SYNDROME 5; AGS5		20q11.23		
#613075	MACS SYNDROME		20p11.23		
#613406	WITTEVEEN-KOLK SYNDROME; WITKOS	CHROMOSOME 15q24 DELETION SYNDROME, INCLUDED	15q24.2		
#609241	SCHINDLER DISEASE, TYPE I	ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE III, INCLUDED	22q13.2		
#613641	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB		16q23.1		
#613845	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS		19q13.2		
#615919	ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2		20p12.3		
#615938	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3		12p13.32		
#615985	BARDET-BIEDL SYNDROME 8; BBS8		14q31.3		
#615990	BARDET-BIEDL SYNDROME 13; BBS13		17q22		
#616202	CEREBELLOFACIODENTAL SYNDROME; CFDS		14q32.33		
#616281	NEURODEVELOPMENTAL DISORDER WITH SPASTIC PARAPLEGIA AND MICROCEPHALY; NEDSPM		16q11.2		
#616335	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3		15q15.3		
#616353	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6; DKCB6		16p13.12		
#616490	JOUBERT SYNDROME 23; JBTS23		14q23.1		
#616553	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 7, INCLUDED; DKCB7, INCLUDED	16q22.1		
#616688	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z		22q12.2		
#617120	JOUBERT SYNDROME 27; JBTS27		17p11.2		
#617121	JOUBERT SYNDROME 28; JBTS28		17q22		
#617219	CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL		19q13.11	19:31900000-35100000	
#617516	STANKIEWICZ-ISIDOR SYNDROME; STISS		17q24.2		
#617604	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA		21q22.11		
#618010	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17		14q24.1		
#618097	MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2		17p11.2		
#618120	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5		19p13.3		
#618164	CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD		16p13.3		
#618347	GALLOWAY-MOWAT SYNDROME 6; GAMOS6		21q22.3		
#618832	EPILEPSY, EARLY-ONSET, WITH OR WITHOUT DEVELOPMENTAL DELAY; EPEDD		16p11.2		







